Istituto Oncologico Veneto IRCCS
The Veneto region's OECI-accredited comprehensive cancer centre in Padua, strong in breast cancer trials, melanoma and tumour immunology.
Overview
Founded in 2005, the Istituto Oncologico Veneto is the IRCCS cancer institute of the Veneto region and coordinates the regional oncology network; it is accredited by the OECI as a comprehensive cancer centre. Pierfranco Conte and Valentina Guarneri's breast oncology group led the ShortHER trial of trastuzumab duration and many neoadjuvant studies, the melanoma unit is a leading Italian immunotherapy trial site, and Vincenzo Bronte's immunology programme is known for myeloid-derived suppressor cells. The institute runs gastrointestinal, thoracic and gynaecological oncology, radiotherapy and nuclear medicine across Padua and Castelfranco Veneto, with a phase 1 unit and the University of Padua's oncology school.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Istituto Oncologico Veneto, including child institutions. 967 works · 13,434 citations · 77% open access · 19% clinical trials · 2% reviews.
- Sara Lonardi265 works
- Chiara Cremolini177 works
- Filippo Pietrantonio131 works
- Francesca Bergamo127 works
- Matteo Fassan81 works
- Valentina Guarneri76 works
- Lisa Salvatore63 works
- Daniele Rossini61 works
- Marco Maria Germani59 works
- Vanna Chiarion‐Sileni57 works
- Breast cancer trials
- Melanoma immunotherapy
- Tumour immunology (myeloid cells)
- Veneto oncology network
- Phase 1 unit